BLTE vs MANE: stock comparison and AI forecast
Belite Bio, Inc (BLTE) and Veradermics, Inc (MANE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BLTE Belite Bio, Inc
- Market Cap
- $6.05B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
MANE Veradermics, Inc
- Market Cap
- $5.41B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BLTE is 1.1 times larger than MANE by market capitalization ($6.05B against $5.41B).
- BLTE carries 0.01 times debt per unit of equity, against 0.01 times for MANE.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BLTE | MANE |
|---|---|---|
| Market Cap | $6.05B | $5.41B |
| P/B Ratio | 7.85x | 6.65x |
| EPS | $-1.33 | – |
| Book Value/Share | $19.59 | $19.47 |
Profitability & Margins
| Metric | BLTE | MANE |
|---|---|---|
| ROE | -5.1% | – |
| ROA | -5.1% | – |
| ROIC | -5.5% | – |
Financial Health
| Metric | BLTE | MANE |
|---|---|---|
| Current Ratio | 50.02x | 70.53x |
| D/E Ratio | 0.01x | 0.01x |
| Financial Leverage | 1.01x | 1.01x |
| Interest Coverage | -1266.7x | – |
| Working Capital | $484M | $813M |
Cash Flow
| Metric | BLTE | MANE |
|---|---|---|
| Operating Cash Flow | -$27M | – |
Income Statement
| Metric | BLTE | MANE |
|---|---|---|
| Operating Income | -$42M | – |
| Net Income | -$40M | – |
| R&D Expense | $27M | – |
Dividend & Shareholder Information
| Metric | BLTE | MANE |
|---|---|---|
| Shares Outstanding | 39M | 42M |
BLTE vs MANE: stock comparison and AI forecast
Which is bigger, BLTE or MANE?
BLTE is 1.1 times larger than MANE by market capitalization ($6.05B against $5.41B).
Which one does Intratio's AI model rank higher, BLTE or MANE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.